Skip to content Skip to navigation


Methadone remains vital in buprenorphine era

October 20, 2016  |  Alison Knopf, Contributing Writer
Opioid treatment leaders see the two main medication treatments for opioid use disorders as complementary options.

Conference report: Presenter shows unbridled enthusiasm for methadone, buprenorphine

September 10, 2016  |  Gary A. Enos, Editor
A physician presenting at the Cape Cod Symposium on Addictive Disorders endorsed much wider access to both methadone and buprenorphine treatment for opioid dependence.

Well-meaning friends fuel pain-drug misuse

September 9, 2016  |  Julie Miller, Editor in Chief
SAMHSA's National Survey on Drug Use and Health released Thursday collected data on misuse of prescription psychotherapeutic drugs in 2015 and found that 53.7% of those who reported misuse of pain drugs said they got them from a friend or relative.

Treatment behind the walls: States gather to share information

August 4, 2016  |  Alison Knopf, Contributing Writer
State correctional systems are gradually coming to realize that they can implement successful in-prison treatment programs with medication treatments at the center.

Pennsylvania designates centers to coordinate publicly funded treatment for opioid dependence

July 18, 2016  |  Gary A. Enos, Editor
State officials in Pennsylvania believe a "hub-and-spoke" model emphasizing coordinated care and medication-assisted treatment will improve outcomes for Medicaid beneficiaries with opioid use disorders.

A malpractice case holds lessons for opioid addiction treatment

July 15, 2016  |  Luis Giuffra, MD, PhD
The medical director of St. Louis-based Clayton Behavioral says more treatment providers need to embrace the evidence supporting medication treatments such as buprenorphine.

Feds announce more opioid-focused initiatives, including hike in buprenorphine cap to 275

July 6, 2016  |  Gary A. Enos, Editor
A final rule that will take effect in early August will increase the number of patients an individual physician can treat with buprenorphine from 100 to 275, federal officials announced on Tuesday.

Report: States missing the mark on protecting public from opioid overdose

June 28, 2016  |  Gary A. Enos, Editor
The National Safety Council states in a new report that only four states meet five of six indicators of progress in combating the opioid overdose crisis, with no states meeting all six criteria.

Buprenorphine implant shows positive results in newly released data

June 17, 2016  |  Gary A. Enos, Editor
The recently approved six-month buprenorphine implant Probuphine showed greater efficacy than sublingual buprenorphine in data released this week.

First buprenorphine implant receives long-awaited FDA approval

May 27, 2016  |  Gary A. Enos, Editor
A six-month subdermal implant of the opioid treatment drug buprenorphine has received Food and Drug Administration (FDA) approval, and is being seen as an enhancement of medication-assisted treatment approaches.

Grant will expand local training of health professionals in MAT

May 20, 2016  |  Tom Valentino, Senior Editor
A $3 million federal grant will fund the expansion of the opioid treatment-focused Providers' Clinical Support System for Medication Assisted Treatment initiative.

Mobile app assists patients receiving Suboxone film

April 21, 2016  |  Gary A. Enos, Editor
The Suboxone Sublingual Film Mobile Health Library includes features such as symptom tracking for patients receiving the medication for opioid dependence.


Subscribe to Suboxone